Autophagy and heart disease: Implications for cardiac ischemia-reperfusion damage

Current Molecular Medicine

Volumn 14, Issue 5, 2014, Pages 616-629

  Ghavami, S ^a,b   Gupta, S ^a,b   Ambrose, E ^a,b   Hnatowich, M ^a,b   Freed, D H ^a,b   Dixon, I M C ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b St Boniface Research Centre   (Canada)

Author keywords

Autophagy; Heart; Heart disease; Ischemia reperfusion; Mitophagy

Indexed keywords

BECLIN 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PARKIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P62; PROTEIN P63; RAB PROTEIN; THYMOCYTE ANTIBODY; TUBERIN; UNCLASSIFIED DRUG;

AUTOPHAGOSOME; AUTOPHAGY; CELL SURVIVAL; DIABETIC CARDIOMYOPATHY; DOWNREGULATION; GENDER; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; MITOCHONDRION; MITOPHAGY; NONHUMAN; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; HEART DISEASE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

AUTOPHAGY; HEART DISEASES; HUMANS; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; REPERFUSION INJURY;

EID: 84904046211     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524014666140603101520     Document Type: Review

References (120)

1. Tsutsui H, Tsuchihashi-Makaya M, Kinugawa S, Goto D, Takeshita A. Clinical characteristics and outcome of hospitalized patients with heart failure in Japan. Circulation J 2006; 70(12): 1617-23.
2. Gottlieb RA, Mentzer RM, Jr. Autophagy: an affair of the heart. Heart Fail Rev 2013; 18(5): 575-84.
3. Dunlay SM, Shah ND, Shi Q, et al. Lifetime costs of medical care after heart failure diagnosis. Circ Cardiovasc Qual Outcomes 2011; 4(1): 68-75.
4. Kanamori H, Takemura G, Goto K, et al. The role of autophagy emerging in postinfarction cardiac remodelling. Cardiovasc Res 2011; 91(2): 330-9.
5. Wang EY, Biala AK, Gordon JW, Kirshenbaum LA. Autophagy in the heart: too much of a good thing? J Cardiovasc Pharmacol 2012; 60(2): 110-7.
6. Beau I, Mehrpour M, Codogno P. Autophagosomes and human diseases. Int J Biochem Cell Biol 2011; 43(4): 460-4.
7. Abounit K, Scarabelli TM, McCauley RB. Autophagy in mammalian cells. World J Biol Chem 2012; 3(1): 1-6.
8. Yoshimori T. [Autophagy as a bulk protein degradation system: it plays various roles]. Tanpakushitsu Kakusan Koso 2004; 49(7 Suppl): 1029-32.
9. Klionsky DJ, Abdalla FC, Abeliovich H, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8(4): 445-544.
10. Ghavami S, Eshragi M, Ande SR, et al. S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell Res 2010; 20(3): 314-31.
11. Ghavami S, Mutawe MM, Sharma P, et al. Mevalonate cascade regulation of airway mesenchymal cell autophagy and apoptosis: a dual role for p53. PLoS One 2011; 6(1): e16523.
12. Gustafsson AB, Gottlieb RA. Autophagy in ischemic heart disease. Circ Res 2009; 104(2): 150-8.
13. Rotter D, Rothermel BA. Targets, trafficking, and timing of cardiac autophagy. Pharmacol Res 2012; 66(6): 494-504.
14. Ghavami S, Cunnington RH, Yeganeh B, et al. Autophagy regulates trans fatty acid-mediated apoptosis in primary cardiac myofibroblasts. Biochim Biophys Acta 2012; 1823(12): 2274-86.
15. Yeganeh B, Rezaei Moghadam A, Tran AT, et al. Asthma and influenza virus infection:focusing on cell death and stress pathways in influenza virus replication. Iran J Allergy Asthma Immunol 2013; 12(1): 1-17.
16. Gong C, Bauvy C, Tonelli G, et al. Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stemlike/ progenitor cells. Oncogene 2013; 32(18): 2261-72, 2272e.1-11.
17. Nakatogawa H, Suzuki K, Kamada Y, Ohsumi Y. Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat Rev Mol Cell Biol 2009; 10(7): 458-67.
18. Ghavami S, Yeganeh B, Stelmack GL, et al. Apoptosis, autophagy and ER stress in mevalonate cascade inhibitioninduced cell death of human atrial fibroblasts. Cell Death Dis 2012; 3: e330.
19. Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 2011; 18(4): 571-80.
20. Wu YT, Tan HL, Shui G, et al. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem 2010; 285(14): 10850-61.
21. Hanada T, Noda NN, Satomi Y, et al. The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy. J Biol Chem 2007; 282(52): 37298-302.
22. Rubinsztein DC, Cuervo AM, Ravikumar B, et al. In search of an autophagomometer. Autophagy 2009; 5(5): 585-9.
23. Jangamreddy JR, Ghavami S, Grabarek J, et al. Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: differences between primary and cancer cells. Biochim Biophys Acta 2013; 1833(9): 2057-69.
24. Ravikumar B, Sarkar S, Davies JE, et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 2010; 90(4): 1383-435.
25. Del Principe D, Lista P, Malorni W, Giammarioli AM. Fibroblast autophagy in fibrotic disorders. J Pathol 2013; 229(2): 208-20.
26. Inoki K, Kim J, Guan KL. AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol Toxicol 2012; 52: 381-400.
27. Nemchenko A, Chiong M, Turer A, Lavandero S, Hill JA. Autophagy as a therapeutic target in cardiovascular disease. J Mol Cell Cardiol 2011; 51(4): 584-93.
28. Neufeld TP. TOR-dependent control of autophagy: biting the hand that feeds. Curr Opin Cell Biol 2010; 22(2): 157-68.
29. Huang J, Manning BD. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 2008; 412(2): 179-90.
30. Marshall CB, Ho J, Buerger C, et al. Characterization of the intrinsic and TSC2-GAP-regulated GTPase activity of Rheb by real-time NMR. Sci Signal 2009; 2(55): ra3.
31. Sciarretta S, Hariharan N, Monden Y, Zablocki D, Sadoshima J. Is autophagy in response to ischemia and reperfusion protective or detrimental for the heart? Pediatr Cardiol 2011; 32(3): 275-81.
32. Jewell JL, Guan KL. Nutrient signaling to mTOR and cell growth. Trends Biochem Sci 2013; 38(5): 233-42.
33. Ramirez-Peinado S, Leon-Annicchiarico CL, Galindo-Moreno J, et al. Glucose starved cells do not engage in pro-survival autophagy. J Biol Chem 2013; 288(42): 30387-98.
34. Maddocks OD, Vousden KH. Metabolic regulation by p53. J Mol Med (Berl) 2011; 89(3): 237-45.
35. Mah LY, O'Prey J, Baudot AD, Hoekstra A, Ryan KM. DRAM-1 encodes multiple isoforms that regulate autophagy. Autophagy 2012; 8(1): 18-28.
36. Ghavami S, Mutawe MM, Schaafsma D, et al. Geranylgeranyl transferase 1 modulates autophagy and apoptosis in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2012; 302(4): L420-8.
37. Roach PJ. AMPK-> ULK1-> autophagy. Mol Cell Biol 2011; 31(15): 3082-4.
38. Gabernet-Castello C, O'Reilly AJ, Dacks JB, Field MC. Evolution of Tre-2/Bub2/Cdc16 (TBC) Rab GTPaseactivating proteins. Mol Biol Cell 2013; 24(10): 1574-83.
39. Wang S, Song P, Zou MH. AMP-activated protein kinase, stress responses and cardiovascular diseases. Clin Sci (Lond) 2012; 122(12): 555-73.
40. Mizushima N. The role of the Atg1/ULK1 complex in autophagy regulation. Curr Opin Cell Biol 2010; 22(2): 132-9.
41. Gammoh N, Florey O, Overholtzer M, Jiang X. Interaction between FIP200 and ATG16L1 distinguishes ULK1 complexdependent and-independent autophagy. Nat Str Mol Biol 2013; 20(2): 144-9.
42. Raben N, Hill V, Shea L, et al. Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease. Hum Mol Genet 2008; 17(24): 3897-908.
43. Paiva MA, Rutter-Locher Z, Goncalves LM, et al. Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury. Am J Physiol Heart Circ Physiol 2011; 300(6): H2123-34.
44. Xie Z, He C, Zou MH. AMP-activated protein kinase modulates cardiac autophagy in diabetic cardiomyopathy. Autophagy 2011; 7(10): 1254-5.
45. Fonarow GC, Srikanthan P. Diabetic cardiomyopathy. Endocrinol Metab Clin North Am 2006; 35(3): 575-99, ix.
46. Huang J, Lam GY, Brumell JH. Autophagy signaling through reactive oxygen species. Antioxid Redox Signal 2011; 14(11): 2215-31.
47. Bellot G, Garcia-Medina R, Gounon P, et al. Hypoxiainduced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 2009; 29(10): 2570-81.
48. Semenza GL. Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim Biophys Acta 2011; 1813(7): 1263-8.
49. Semenza GL. Hypoxia-Inducible Factor 1 and Cardiovascular Disease. Annu Rev Physiol 2014; 76: 39-56.
50. Wei H, Bedja D, Koitabashi N, et al. Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-beta signaling. Proc Natl Acad Sci U S A 2012; 109(14): E841-50.
51. Frohlich ED, Apstein C, Chobanian AV, et al. The heart in hypertension. The N Engl J Med 1992; 327(14): 998-1008.
52. Ouma GO, Rodriguez E, Muthumani K, Weiner DB, Wilensky RL, Mohler ER, 3rd. In vivo electroporation of constitutively expressed HIF-1alpha plasmid DNA improves neovascularization in a mouse model of limb ischemia. J Vasc Surg 2014; 59(3): 786-93.
53. Walton CB, Ecker J, Anderson CD, Outten JT, Allison RZ, Shohet RV. Cardiac angiogenesis directed by stable Hypoxia Inducible Factor-1. Vasc Cell 2013; 5(1): 15.
54. Krishnan J, Suter M, Windak R, et al. Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell Metab 2009; 9(6): 512-24.
55. Kubli DA, Gustafsson AB. Mitochondria and mitophagy: the yin and yang of cell death control. Circ Res 2012; 111(9): 1208-21.
56. Scherz-Shouval R, Elazar Z. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol 2007; 17(9): 422-7.
57. Crompton M, Virji S, Doyle V, Johnson N, Ward JM. The mitochondrial permeability transition pore. Biochem Soc Symp 1999; 66: 167-79.
58. Jin SM, Youle RJ. PINK1-and Parkin-mediated mitophagy at a glance. J Cell Sci 2012; 125(Pt 4): 795-9.
59. Hirota Y, Kang D, Kanki T. The physiological role of mitophagy: new insights into phosphorylation events. Int J Cell Biol 2012; 2012: 354914.
60. Bjorkoy G, Lamark T, Pankiv S, Overvatn A, Brech A, Johansen T. Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol 2009; 452: 181-97.
61. Hoshino A, Mita Y, Okawa Y, et al. Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart. Nat Commun 2013; 4: 2308.
62. Gupta A, Rohlfsen C, Leppo MK, et al. Creatine Kinase-Overexpression Improves Myocardial Energetics, Contractile Dysfunction and Survival in Murine Doxorubicin Cardiotoxicity. PLoS One 2013; 8(10): e74675.
63. Zhu F, Li Y, Zhang J, et al. Senescent cardiac fibroblast is critical for cardiac fibrosis after myocardial infarction. PLoS One 2013; 8(9): e74535.
64. Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol 2012; 298: 229-317.
65. Shintani-Ishida K, Inui M, Yoshida K. Ischemia-reperfusion induces myocardial infarction through mitochondrial Ca(2)(+) overload. J Mol Cell Cardiol 2012; 53(2): 233-9.
66. Padilla F, Garcia-Dorado D, Agullo L, et al. L-Arginine administration prevents reperfusion-induced cardiomyocyte hypercontracture and reduces infarct size in the pig. Cardiovasc Res 2000; 46(3): 412-20.
67. Loos B, Genade S, Ellis B, Lochner A, Engelbrecht AM. At the core of survival: autophagy delays the onset of both apoptotic and necrotic cell death in a model of ischemic cell injury. Exp Cell Res 2011; 317(10): 1437-53.
68. Matsui Y, Takagi H, Qu X, et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMPactivated protein kinase and Beclin 1 in mediating autophagy. Circ Res 2007; 100(6): 914-22.
69. Yan L, Vatner DE, Kim SJ, et al. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci U S A 2005; 102(39): 13807-12.
70. French CJ, Taatjes DJ, Sobel BE. Autophagy in myocardium of murine hearts subjected to ischemia followed by reperfusion. Histochem Cell Biol 2010; 134(5): 519-26.
71. Rifki OF, Hill JA. Cardiac autophagy: good with the bad. J Cardiovasc Pharmacol 2012; 60(3): 248-52.
72. Nishida K, Kyoi S, Yamaguchi O, Sadoshima J, Otsu K. The role of autophagy in the heart. Cell Death Differ 2009; 16(1): 31-8.
73. Decker RS, Wildenthal K. Lysosomal alterations in hypoxic and reoxygenated hearts. I. Ultrastructural and cytochemical changes. Am J Pathol 1980; 98(2): 425-44.
74. Huang C, Andres AM, Ratliff EP, Hernandez G, Lee P, Gottlieb RA. Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS One 2011; 6(6): e20975.
75. Decker RS, Decker ML, Herring GH, Morton PC, Wildenthal K. Lysosomal vacuolar apparatus of cardiac myocytes in heart of starved and refed rabbits. J Mol Cell Cardiol 1980; 12(11): 1175-89.
76. Ma X, Liu H, Foyil SR, et al. Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation 2012; 125(25): 3170-81.
77. Eskelinen EL, Illert AL, Tanaka Y, et al. Role of LAMP-2 in lysosome biogenesis and autophagy. Mol Biol Cell 2002; 13(9): 3355-68.
78. Campesi I, Straface E, Occhioni S, Montella A, Franconi F. Protein oxidation seems to be linked to constitutive autophagy: a sex study. Life Sci 2013; 93(4): 145-52.
79. Malorni W, Campesi I, Straface E, Vella S, Franconi F. Redox features of the cell: a gender perspective. Antioxid Redox Signal 2007; 9(11): 1779-801.
80. Lee J, Giordano S, Zhang J. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J 2012; 441(2): 523-40.
81. Cosper PF, Leinwand LA. Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner. Cancer Res 2011; 71(5): 1710-20.
82. Chen C, Hu LX, Dong T, et al. Apoptosis and autophagy contribute to gender difference in cardiac ischemiareperfusion induced injury in rats. Life Sci 2013; 93(7): 265-70.
83. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 2005; 308(5728): 1583-7.
84. Galluzzi L, Kepp O, Trojel-Hansen C, Kroemer G. Mitochondrial control of cellular life, stress, and death. Circ Res 2012; 111(9): 1198-207.
85. Fader CM, Sanchez D, Furlan M, Colombo MI. Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in k562 cells. Traffic 2008; 9(2): 230-50.
86. Longatti A, Lamb CA, Razi M, Yoshimura S, Barr FA, Tooze SA. TBC1D14 regulates autophagosome formation via Rab11-and ULK1-positive recycling endosomes. J Cell Biol 2012; 197(5): 659-75.
87. Matsui T, Fukuda M. Rab12 regulates mTORC1 activity and autophagy through controlling the degradation of amino-acid transporter PAT4. EMBO Rep 2013; 14(5): 450-7.
88. Heublein S, Kazi S, Ogmundsdottir MH, et al. Protonassisted amino-acid transporters are conserved regulators of proliferation and amino-acid-dependent mTORC1 activation. Oncogene 2010; 29(28): 4068-79.
89. Zoncu R, Bar-Peled L, Efeyan A, Wang S, Sancak Y, Sabatini DM. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science 2011; 334(6056): 678-83.
90. Hochstrasser M. Ubiquitin-dependent protein degradation. Annu Rev Genet 1996; 30: 405-39.
91. Willis MS, Patterson C. Into the heart: the emerging role of the ubiquitin-proteasome system. J Mol Cell Cardiol 2006; 41(4): 567-79.
92. Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 2001; 292(5521): 1552-5.
93. Tannous P, Zhu H, Nemchenko A, et al. Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy. Circulation 2008; 117(24): 3070-8.
94. Gong D, Zhang H, Hu S. Mitochondrial aldehyde dehydrogenase 2 activation and cardioprotection. J Mol Cell Cardiol 2013; 55: 58-63.
95. Zhou S, Liu Y, Prater K, Zheng Y, Cai L. Roles of microRNAs in pressure overload-and ischemia-related myocardial remodeling. Life Sci 2013; 93(23): 855-62.
96. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116(2): 281-97.
97. Leite-Moreira AM, Lourenco AP, Falcao-Pires I, Leite-Moreira AF. Pivotal role of microRNAs in cardiac physiology and heart failure. Drug Discov Today 2013; 18(23-24): 1243-9.
98. Kuster DW, Mulders J, Ten Cate FJ, et al. MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations. J Mol Cell Cardiol 2013; 65: 59-66.
99. Cheng Y, Ji R, Yue J, et al. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol 2007; 170(6): 1831-40.
100. Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008; 456(7224): 980-4.
101. Zeng M, Wei X, Wu Z, et al. NF-kappaB-mediated induction of autophagy in cardiac ischemia/reperfusion injury. Biochem Biophys Res Commun 2013; 436(2): 180-5.
102. Onai Y, Suzuki J, Maejima Y, et al. Inhibition of NF-{kappa}B improves left ventricular remodeling and cardiac dysfunction after myocardial infarction. Am J Physiol Heart Circ Physiol 2007; 292(1): H530-8.
103. Kopp EB, Ghosh S. NF-kappa B and rel proteins in innate immunity. Adv Immunol 1995; 58: 1-27.
104. Cadwell K, Liu JY, Brown SL, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 2008; 456(7219): 259-63.
105. Cadwell K, Patel KK, Komatsu M, Virgin HWt, Stappenbeck TS. A common role for Atg16L1, Atg5 and Atg7 in small intestinal Paneth cells and Crohn disease. Autophagy 2009; 5(2): 250-2.
106. Murrow L, Debnath J. Autophagy as a stress-response and quality-control mechanism: implications for cell injury and human disease. Annu Rev Pathol 2013; 8: 105-37.
107. Wang X, Blagden C, Fan J, et al. Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle. Genes Dev 2005; 19(14): 1715-22.
108. Masiero E, Agatea L, Mammucari C, et al. Autophagy is required to maintain muscle mass. Cell Metab 2009; 10(6): 507-15.
109. Shibata M, Lu T, Furuya T, et al. Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1. J Biol Chem 2006; 281(20): 14474-85.
110. Ebato C, Uchida T, Arakawa M, et al. Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. Cell Metab 2008; 8(4): 325-32.
111. Jung HS, Chung KW, Won Kim J, et al. Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia. Cell Metab 2008; 8(4): 318-24.
112. Buss SJ, Muenz S, Riffel JH, et al. Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction. J Am Coll Cardiol 2009; 54(25): 2435-46.
113. Eisen HJ, Tuzcu EM, Dorent R, et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiactransplant recipients. N Engl J Med 2003; 349(9): 847-58.
114. Gadgeel SM, Lew DL, Synold TW, et al. Phase I study evaluating the combination of lapatinib (a Her2/Neu and EGFR inhibitor) and everolimus (an mTOR inhibitor) in patients with advanced cancers: South West Oncology Group (SWOG) Study S0528. Cancer Chemother Pharmacol 2013; 72(5): 1089-96.
115. Eguchi M, Kim YH, Kang KW, et al. Ischemia-reperfusion injury leads to distinct temporal cardiac remodeling in normal versus diabetic mice. PLoS One 2012; 7(2): e30450.
116. Wang JH, Ahn IS, Fischer TD, et al. Autophagy suppresses age-dependent ischemia and reperfusion injury in livers of mice. Gastroenterology 2011; 141(6): 2188-2199.e6.
117. Gracia-Sancho J, Garcia-Caldero H, Hide D, et al. Simvastatin maintains function and viability of steatotic rat livers procured for transplantation. J Hepatol 2013; 58(6): 1140-6.
118. Parajuli N, MacMillan-Crow LA. Role of reduced manganese superoxide dismutase in ischemia-reperfusion injury: a possible trigger for autophagy and mitochondrial biogenesis? Am J Physiol Renal Physiol 2013; 304(3): F257-67.
119. Taherbhoy AM, Tait SW, Kaiser SE, et al. Atg8 transfer from Atg7 to Atg3: a distinctive E1-E2 architecture and mechanism in the autophagy pathway. Mol Cell 2011; 44(3): 451-61.
120. Yoshimori T, Yamamoto A, Moriyama Y, Futai M, Tashiro Y. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem 1991; 266(26): 17707-12.